Year |
Citation |
Score |
2022 |
Barth RF, Carpenter DE. Rodent Brain Tumor Models for Studies Focusing on Boron Neutron Capture Therapy. Cancer Biotherapy & Radiopharmaceuticals. PMID 36125407 DOI: 10.1089/cbr.2022.0041 |
0.449 |
|
2022 |
Sahu U, Barth RF, Otani Y, McCormack R, Kaur B. Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research. Journal of Neuropathology and Experimental Neurology. PMID 35446393 DOI: 10.1093/jnen/nlac021 |
0.411 |
|
2020 |
Wang JL, Barth RF, Cavaliere R, Puduvalli VK, Giglio P, Lonser RR, Elder JB. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. Plos One. 15: e0244383. PMID 33373402 DOI: 10.1371/journal.pone.0244383 |
0.337 |
|
2020 |
Elleaume H, Barth RF, Rousseau J, Bobyk L, Balosso J, Yang W, Huo T, Nakkula R. Radiation therapy combined with intracerebral convection-enhanced delivery of cisplatin or carboplatin for treatment of the F98 rat glioma. Journal of Neuro-Oncology. PMID 32809095 DOI: 10.1007/s11060-020-03600-x |
0.355 |
|
2018 |
Barth RF, Zhang Z, Liu T. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality. Cancer Communications (London, England). 38: 36. PMID 29914575 DOI: 10.1186/s40880-018-0280-5 |
0.303 |
|
2016 |
Barth RF, Wu G, Meisen WH, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B. Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors. Oncotargets and Therapy. 9: 2769-2781. PMID 27274273 DOI: 10.2147/Ott.S99242 |
0.383 |
|
2016 |
Barth RF, Wu G, Hans Meisen W, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B. Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors Oncotargets and Therapy. 9: 2769-2781. DOI: 10.2147/OTT.S99242 |
0.381 |
|
2015 |
Chandra S, Parker DJ, Barth RF, Pannullo SC. Quantitative imaging of magnesium distribution at single-cell resolution in brain tumors and infiltrating tumor cells with secondary ion mass spectrometry (SIMS). Journal of Neuro-Oncology. PMID 26703785 DOI: 10.1007/s11060-015-2022-8 |
0.361 |
|
2015 |
Barth RF, Yang W, Nakkula RJ, Byun Y, Tjarks W, Chu Wu L, Binns PJ, Riley KJ. Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. PMID 26282567 DOI: 10.1016/j.apradiso.2015.06.031 |
0.371 |
|
2014 |
Yang W, Barth RF, Huo T, Nakkula RJ, Weldon M, Gupta N, Agius L, Grecula JC. Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors. Radiation Oncology (London, England). 9: 25. PMID 24422671 DOI: 10.1186/1748-717X-9-25 |
0.374 |
|
2013 |
Chandra S, Barth RF, Haider SA, Yang W, Huo T, Shaikh AL, Kabalka GW. Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas. Plos One. 8: e75377. PMID 24058680 DOI: 10.1371/Journal.Pone.0075377 |
0.376 |
|
2012 |
Huo T, Barth RF, Yang W, Nakkula RJ, Koynova R, Tenchov B, Chaudhury AR, Agius L, Boulikas T, Elleaume H, Lee RJ. Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats. Plos One. 7: e48752. PMID 23152799 DOI: 10.1371/journal.pone.0048752 |
0.411 |
|
2011 |
Barth RF, Yang W, Huo T, Riley KJ, Binns PJ, Grecula JC, Gupta N, Rousseau J, Elleaume H. Comparison of intracerebral delivery of carboplatin and photon irradiation with an optimized regimen for boron neutron capture therapy of the F98 rat glioma. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 69: 1813-6. PMID 21493080 DOI: 10.1016/j.apradiso.2011.03.019 |
0.394 |
|
2011 |
Kawabata S, Yang W, Barth RF, Wu G, Huo T, Binns PJ, Riley KJ, Ongayi O, Gottumukkala V, Vicente MG. Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors. Journal of Neuro-Oncology. 103: 175-85. PMID 20848301 DOI: 10.1007/S11060-010-0376-5 |
0.467 |
|
2011 |
Yang W, Huo T, Barth RF, Gupta N, Weldon M, Grecula JC, Ross BD, Hoff BA, Chou TC, Rousseau J, Elleaume H. Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors. Journal of Neuro-Oncology. 101: 379-90. PMID 20577779 DOI: 10.1007/s11060-010-0272-z |
0.411 |
|
2010 |
Rousseau J, Barth RF, Fernandez M, Adam JF, Balosso J, Estève F, Elleaume H. Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors. Journal of Neuro-Oncology. 98: 287-95. PMID 20012464 DOI: 10.1007/s11060-009-0074-3 |
0.427 |
|
2010 |
Zhang H, Huo T, Barth R. SU-GG-T-123: Theoretical and Experimental Determination of Therapeutic Advantage of Single Fraction Megavoltage Grid Therapy for F98 Glioma Brain Tumor Cell Lines Medical Physics. 37: 3212-3213. DOI: 10.1118/1.3468512 |
0.343 |
|
2010 |
Yang W, Huo T, Barth RF, Gupta N, Weldon M, Grecula JC, Ross BD, Hoff BA, Chou T, Rousseau J, Elleaume H. Erratum to: Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors Journal of Neuro-Oncology. 101: 391-391. DOI: 10.1007/s11060-010-0316-4 |
0.364 |
|
2009 |
Yang W, Barth RF, Wu G, Huo T, Tjarks W, Ciesielski M, Fenstermaker RA, Ross BD, Wikstrand CJ, Riley KJ, Binns PJ. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors. Journal of Neuro-Oncology. 95: 355-65. PMID 19588228 DOI: 10.1007/s11060-009-9945-x |
0.442 |
|
2009 |
Rousseau J, Adam JF, Deman P, Wu TD, Guerquin-Kern JL, Gouget B, Barth RF, Estve F, Elleaume H. Intracerebral delivery of 5-iodo-2′-deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma Journal of Synchrotron Radiation. 16: 573-581. PMID 19535873 DOI: 10.1107/S0909049509016987 |
0.351 |
|
2009 |
Yang W, Barth RF, Wu G, Tjarks W, Binns P, Riley K. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 67: S328-31. PMID 19467880 DOI: 10.1016/j.apradiso.2009.03.030 |
0.385 |
|
2009 |
Barth RF. Boron neutron capture therapy at the crossroads: challenges and opportunities. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 67: S3-6. PMID 19467879 DOI: 10.1016/j.apradiso.2009.03.102 |
0.382 |
|
2009 |
Barth RF, Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. Journal of Neuro-Oncology. 94: 299-312. PMID 19381449 DOI: 10.1007/S11060-009-9875-7 |
0.436 |
|
2009 |
Rousseau J, Barth RF, Moeschberger ML, Elleaume H. Efficacy of intracerebral delivery of Carboplatin in combination with photon irradiation for treatment of F98 glioma-bearing rats. International Journal of Radiation Oncology, Biology, Physics. 73: 530-6. PMID 19147017 DOI: 10.1016/J.Ijrobp.2008.09.018 |
0.315 |
|
2008 |
Barth RF, Yang W, Wu G, Swindall M, Byun Y, Narayanasamy S, Tjarks W, Tordoff K, Moeschberger ML, Eriksson S, Binns PJ, Riley KJ. Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors. Proceedings of the National Academy of Sciences of the United States of America. 105: 17493-7. PMID 18981415 DOI: 10.1073/Pnas.0809569105 |
0.45 |
|
2007 |
Rousseau J, Boudou C, Barth RF, Balosso J, Estève F, Elleaume H. Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5195-201. PMID 17726137 DOI: 10.1158/1078-0432.CCR-07-1002 |
0.328 |
|
2006 |
Byun Y, Thirumamagal BTS, Yang W, Eriksson S, Barth RF, Tjarks W. Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors Journal of Medicinal Chemistry. 49: 5513-5523. PMID 16942024 DOI: 10.1021/jm060413w |
0.337 |
|
2006 |
Yang W, Barth RF, Wu G, Kawabata S, Sferra TJ, Bandyopadhyaya AK, Tjarks W, Ferketich AK, Moeschberger ML, Binns PJ, Riley KJ, Coderre JA, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3792-802. PMID 16778107 DOI: 10.1158/1078-0432.Ccr-06-0141 |
0.441 |
|
2006 |
Wu G, Barth RF, Yang W, Lee RJ, Tjarks W, Backer MV, Backer JM. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anti-Cancer Agents in Medicinal Chemistry. 6: 167-84. PMID 16529539 DOI: 10.2174/187152006776119153 |
0.367 |
|
2006 |
Wu G, Barth RF, Yang W, Kawabata S, Zhang L, Green-Church K. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates. Molecular Cancer Therapeutics. 5: 52-9. PMID 16432162 DOI: 10.1158/1535-7163.MCT-05-0325 |
0.377 |
|
2005 |
Yang W, Barth RF, Wu G, Ciesielski MJ, Fenstermaker RA, Moffat BA, Ross BD, Wikstrand CJ. Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 341-50. PMID 15671565 |
0.394 |
|
2004 |
Yang W, Barth RF, Wu G, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Binns PJ, Riley K, Patel H, Coderre JA, Ciesielski MJ, Fenstermaker RA. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 61: 981-5. PMID 15308179 DOI: 10.1016/j.apradiso.2004.05.071 |
0.382 |
|
2004 |
Barth RF, Wu G, Yang W, Binns PJ, Riley KJ, Patel H, Coderre JA, Tjarks W, Bandyopadhyaya AK, Thirumamagal BT, Ciesielski MJ, Fenstermaker RA. Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 61: 899-903. PMID 15308165 DOI: 10.1016/j.apradiso.2004.05.004 |
0.361 |
|
2004 |
Wu G, Barth RF, Yang W, Chatterjee M, Tjarks W, Ciesielski MJ, Fenstermaker RA. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjugate Chemistry. 15: 185-94. PMID 14733599 DOI: 10.1021/bc0341674 |
0.406 |
|
2004 |
Barth RF, Grecula JC, Yang W, Rotaru JH, Nawrocky M, Gupta N, Albertson BJ, Ferketich AK, Moeschberger ML, Coderre JA, Rofstad EK. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors. International Journal of Radiation Oncology, Biology, Physics. 58: 267-77. PMID 14697448 DOI: 10.1016/S0360-3016(03)01613-4 |
0.47 |
|
2003 |
Stephenson SM, Yang W, Stevens PJ, Tjarks W, Barth RF, Lee RJ. Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy. Anticancer Research. 23: 3341-5. PMID 12926073 |
0.325 |
|
2003 |
Gibson CR, Staubus AE, Barth RF, Yang W, Ferketich AK, Moeschberger MM. Pharmacokinetics of sodium borocaptate: A critical assessment of dosing paradigms for boron neutron capture therapy Journal of Neuro-Oncology. 62: 157-169. PMID 12749711 DOI: 10.1007/Bf02699942 |
0.326 |
|
2003 |
Barth RF, Yang W, Coderre JA. Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation. Journal of Neuro-Oncology. 62: 61-74. PMID 12749703 |
0.534 |
|
2003 |
Barth RF. A critical assessment of boron neutron capture therapy: an overview. Journal of Neuro-Oncology. 62: 1-5. PMID 12749698 |
0.323 |
|
2003 |
Roychowdhury S, Peng R, Baiocchi RA, Bhatt D, Vourganti S, Grecula J, Gupta N, Eisenbeis CF, Nuovo GJ, Yang W, Schmalbrock P, Ferketich A, Moeschberger M, Porcu P, Barth RF, et al. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Research. 63: 965-71. PMID 12615710 |
0.33 |
|
2002 |
Yang W, Barth RF, Adams DM, Ciesielski MJ, Fenstermaker RA, Shukla S, Tjarks W, Caligiuri MA. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. Cancer Research. 62: 6552-8. PMID 12438250 |
0.36 |
|
2002 |
Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. Cancer Research. 62: 3159-66. PMID 12036929 |
0.398 |
|
2002 |
Barth RF, Yang W, Bartus RT, Rotaru JH, Ferketich AK, Moeschberger ML, Nawrocky MM, Coderre JA, Rofstad EK. Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine. International Journal of Radiation Oncology, Biology, Physics. 52: 858-68. PMID 11849812 DOI: 10.1016/S0360-3016(01)02734-1 |
0.531 |
|
2001 |
Yang W, Barth RF, Leveille R, Adams DM, Ciesielski M, Fenstermaker RA, Capala J. Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent. Journal of Neuro-Oncology. 55: 19-28. PMID 11804279 DOI: 10.1023/A:1013017821166 |
0.446 |
|
2000 |
Yang W, Barth RF, Rotaru JH, Boesel CP, Wilkie DA, Bresnahan JC, Hadjiconstantinou M, Goettl VM, Joel DD, Nawrocky MM. Boron neutron capture therapy of brain tumors: functional and neuropathologic effects of blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Journal of Neuro-Oncology. 48: 179-90. PMID 11100816 DOI: 10.1023/A:1006410611067 |
0.489 |
|
2000 |
Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, et al. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas. Neurosurgery. 47: 608-21; discussion 6. PMID 10981748 DOI: 10.1097/00006123-200009000-00016 |
0.391 |
|
2000 |
Yang W, Barth RF, Bartus RT, Rotaru JH, Moeschberger ML, Ferketich AK, Nawrocky MM, Coderre JA, Goodman JH. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine. Neurosurgery. 47: 189-97; discussion 1. PMID 10917362 DOI: 10.1097/00006123-200007000-00039 |
0.533 |
|
2000 |
Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. International Journal of Radiation Oncology, Biology, Physics. 47: 209-18. PMID 10758326 DOI: 10.1016/S0360-3016(00)00421-1 |
0.522 |
|
1999 |
Barth RF, Yang W, Bartus RT, Moeschberger ML, Goodman JH. Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7). Neurosurgery. 44: 351-9; discussion 35. PMID 9932889 DOI: 10.1097/00006123-199902000-00062 |
0.517 |
|
1998 |
Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. Journal of Neuro-Oncology. 36: 91-102. PMID 9525831 DOI: 10.1023/A:1005805203044 |
0.419 |
|
1997 |
Capala J, Barth RF, Bailey MQ, Fenstermaker RA, Marek MJ, Rhodes BA. Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats. Bioconjugate Chemistry. 8: 289-95. PMID 9177833 DOI: 10.1021/BC970031S |
0.401 |
|
1997 |
Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine. Journal of Neuro-Oncology. 33: 59-70. PMID 9151224 DOI: 10.1023/A:1005769214899 |
0.506 |
|
1997 |
Soloway AH, Barth RF, Gahbauer RA, Blue TE, Goodman JH. The rationale and requirements for the development of boron neutron capture therapy of brain tumors. Journal of Neuro-Oncology. 33: 9-18. PMID 9151219 DOI: 10.1023/A:1005753610355 |
0.313 |
|
1997 |
Barth RF, Soloway AH. Boron neutron capture therapy of brain tumors--current status and future prospects. Journal of Neuro-Oncology. 33: 3-7. PMID 9151218 DOI: 10.1023/A:1005783531660 |
0.381 |
|
1997 |
Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption. International Journal of Radiation Oncology, Biology, Physics. 37: 663-72. PMID 9112465 DOI: 10.1016/S0360-3016(96)00082-X |
0.506 |
|
1996 |
Barth RF, Soloway AH, Brugger RM. Boron neutron capture therapy of brain tumors: past history, current status, and future potential. Cancer Investigation. 14: 534-50. PMID 8951358 DOI: 10.3109/07357909609076899 |
0.348 |
|
1996 |
Capala J, Barth RF, Bendayan M, Lauzon M, Adams DM, Soloway AH, Fenstermaker RA, Carlsson J. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors. Bioconjugate Chemistry. 7: 7-15. PMID 8741985 DOI: 10.1021/bc950077q |
0.302 |
|
1996 |
Yang W, Barth RF, Carpenter DE, Moeschberger ML, Goodman JH. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption. Neurosurgery. 38: 985-92. PMID 8727825 DOI: 10.1097/00006123-199605000-00027 |
0.459 |
|
1994 |
Matalka KZ, Barth RF, Staubus AE, Moeschberger ML, Coderre JA. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent Radiation Research. 137: 44-51. PMID 8265787 DOI: 10.2307/3578789 |
0.476 |
|
1994 |
Barth RF, Matalka KZ, Bailey MQ, Staubus AE, Soloway AH, Moeschberger ML, Coderre JA, Rofstad EK. A nude rat model for neutron capture therapy of human intracerebral melanoma International Journal of Radiation Oncology, Biology, Physics. 28: 1079-1088. PMID 8175392 DOI: 10.1016/0360-3016(94)90481-2 |
0.449 |
|
1994 |
Barth RF, Soloway AH. Boron neutron capture therapy of primary and metastatic brain tumors. Molecular and Chemical Neuropathology. 21: 139-54. PMID 8086033 DOI: 10.1007/BF02815348 |
0.41 |
|
1990 |
Clendenon NR, Barth RF, Gordon WA, Goodman JH, Alam F, Staubus AE, Boesel CP, Yates AJ, Moeschberger ML, Fairchild RG. Boron neutron capture therapy of a rat glioma. Neurosurgery. 26: 47-55. PMID 2294479 DOI: 10.1097/00006123-199001000-00007 |
0.476 |
|
1990 |
Goodman JH, McGregor JM, Clendenon NR, Gahbauer RA, Barth RF, Soloway AH, Fairchild RG. Inhibition of tumor growth in a glioma model treated with boron neutron capture therapy. Neurosurgery. 27: 383-8. PMID 2234330 DOI: 10.1097/00006123-199009000-00007 |
0.416 |
|
1989 |
Goodman JH, McGregor JM, Clendenon NR, Gahbauer RA, Barth RF, Soloway AH, Fairchild RG. Ultrastructural microvascular response to boron neutron capture therapy in an experimental model. Neurosurgery. 24: 701-8. PMID 2716978 DOI: 10.1227/00006123-198905000-00007 |
0.407 |
|
Show low-probability matches. |